Related Experiment Videos

Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein

M K Chelbi-Alix1, F Quignon, L Pelicano

  • 1CNRS UPR 9051, Centre Hayem, Hôpital St. Louis, Paris, France. mchelbi@infobiogen.fr

Journal of Virology
|January 28, 1998
PubMed

Insights

The promyelocytic leukemia (PML) protein, induced by interferon, provides resistance against certain viral infections by interfering with viral synthesis. PML

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Interferon (IFN) treatment induces cellular antiviral states.
  • Promyelocytic leukemia (PML) protein localizes to nuclear bodies (NBs).
  • The function of NBs and the role of PML in antiviral defense are largely unknown.

Purpose of the Study:

  • To investigate the antiviral potential of the PML protein.
  • To determine if PML contributes to the interferon-induced antiviral state.

Main Methods:

  • Overexpression of PML and Sp100 proteins in cells.
  • Infection assays using vesicular stomatitis virus (VSV), influenza A virus, and encephalomyocarditis virus (EMCV).
  • Analysis of viral mRNA and protein synthesis.
  • Site-directed mutagenesis of the PML protein (coiled-coil domain deletion).

Main Results:

  • PML overexpression conferred resistance to VSV and influenza A virus, but not EMCV.
  • Antiviral effect was dependent on PML expression levels and viral multiplicity of infection, reaching up to 100-fold inhibition.
  • PML interfered with VSV mRNA and protein synthesis.
  • Deletion of the PML coiled-coil domain abolished antiviral activity, while NB localization was not essential.
  • PML's antiviral activity was less potent than the IFN-mediator MxA protein.

Conclusions:

  • PML protein possesses antiviral activity against specific RNA viruses.
  • PML contributes to the antiviral state induced by interferon.
  • The coiled-coil domain of PML is critical for its antiviral function.

Related Concept Videos